203 related articles for article (PubMed ID: 36318999)
1. Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Lubrano E; Chan J; Queiro-Silva R; Cauli A; Goel N; Poddubnyy D; Nash P; Gladman DD
J Rheumatol; 2023 Feb; 50(2):279-284. PubMed ID: 36318999
[TBL] [Abstract][Full Text] [Related]
2. Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Leung YY; Korotaeva TV; Candia L; Pedersen SJ; Bautista Molano W; Ruderman EM; Bisoendial R; Perez-Alamino R; Olsder W; Möller B; Grazio S; Gudu T; Mody GM; Pineda C; Raffayova H; Rohekar S; Goldenstein-Schainberg C; Gutierrez Urena SR; Casasola Vargas JC; Meghnathi B; Prasad R; Richette P; Miranda JRS; Malliotis N; Lindqvist U; Simon D; Ezeonyeji A; Soriano ER; FitzGerald O
J Rheumatol; 2023 Jan; 50(1):119-130. PubMed ID: 36243409
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study.
Haroon M; Ahmad M; Baig MN; Mason O; Rice J; FitzGerald O
Arthritis Res Ther; 2018 Apr; 20(1):73. PubMed ID: 29665824
[TBL] [Abstract][Full Text] [Related]
4. Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis.
Yousif P; Nahra V; Khan MA; Magrey M
Joint Bone Spine; 2024 Jan; 91(1):105625. PubMed ID: 37495073
[TBL] [Abstract][Full Text] [Related]
5. Updated guidelines for the management of axial disease in psoriatic arthritis.
Nash P; Lubrano E; Cauli A; Taylor WJ; Olivieri I; Gladman DD
J Rheumatol; 2014 Nov; 41(11):2286-9. PubMed ID: 25362712
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Xu S; Quinn ST; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar A; Østergaard M; Baraliakos X
Trials; 2022 Sep; 23(1):743. PubMed ID: 36064592
[TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Gossec L; Baraliakos X; Kerschbaumer A; de Wit M; McInnes I; Dougados M; Primdahl J; McGonagle DG; Aletaha D; Balanescu A; Balint PV; Bertheussen H; Boehncke WH; Burmester GR; Canete JD; Damjanov NS; Kragstrup TW; Kvien TK; Landewé RBM; Lories RJU; Marzo-Ortega H; Poddubnyy D; Rodrigues Manica SA; Schett G; Veale DJ; Van den Bosch FE; van der Heijde D; Smolen JS
Ann Rheum Dis; 2020 Jun; 79(6):700-712. PubMed ID: 32434812
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
Regierer AC; Weiß A; Proft F; Baraliakos X; Behrens F; Poddubnyy D; Schett G; Lorenz HM; Worsch M; Strangfeld A
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36898762
[TBL] [Abstract][Full Text] [Related]
9. Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Palominos PE; Fernández-Ávila DG; Coates LC; Adebajo A; Toukap AN; Abogamal A; Polachek A; van Kuijk AWR; Caso F; de Marco G; Kaeley GS; Steinkoenig I; Chau J; Feletar M; Vis M; Elkayam O; Sewerin P; d'Angelo S; Aydin SZ; AlShehhi W; Helliwell PS
J Rheumatol; 2023 Feb; 50(2):265-278. PubMed ID: 36319013
[TBL] [Abstract][Full Text] [Related]
10. The Definition and Measurement of Axial Psoriatic Arthritis.
Lubrano E; Parsons WJ; Marchesoni A; Olivieri I; D'Angelo S; Cauli A; Caso F; Costa L; Scarpa R; Brunese L
J Rheumatol Suppl; 2015 Nov; 93():40-2. PubMed ID: 26523055
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Duffin KC; Mazzuoccolo LD; Cura MJ; Esposito M; Fernandez AP; Gisondi P; Giunta A; Hillary T; Piaserico S; Solomon JA; Merola JF
J Rheumatol; 2023 Jan; 50(1):131-143. PubMed ID: 36319014
[TBL] [Abstract][Full Text] [Related]
12. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
Rheumatology (Oxford); 2020 Jun; 59(6):1340-1346. PubMed ID: 31593590
[TBL] [Abstract][Full Text] [Related]
13. Is Axial Psoriatic Arthritis the Same as Ankylosing Spondylitis With Psoriasis: A Debate.
Coates LC; Deodhar A
J Rheumatol; 2023 Nov; 50(Suppl 2):14-17. PubMed ID: 37419625
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.
Zeidler HK
J Clin Rheumatol; 2022 Jan; 28(1):38-43. PubMed ID: 34941618
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Ogdie A; de Vlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Gruben D; Kwok K; Wang C; Hsu MA; Maniccia A
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396519
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis.
Braun J; Kiltz U; Baraliakos X
Expert Opin Biol Ther; 2023 Feb; 23(2):195-206. PubMed ID: 36511882
[TBL] [Abstract][Full Text] [Related]
17. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Gossec L; Kerschbaumer A; Ferreira RJO; Aletaha D; Baraliakos X; Bertheussen H; Boehncke WH; Esbensen BA; McInnes IB; McGonagle D; Winthrop KL; Balanescu A; Balint PV; Burmester GR; Cañete JD; Claudepierre P; Eder L; Hetland ML; Iagnocco A; Kristensen LE; Lories R; Queiro R; Mauro D; Marzo-Ortega H; Mease PJ; Nash P; Wagenaar W; Savage L; Schett G; Shoop-Worrall SJW; Tanaka Y; Van den Bosch FE; van der Helm-van Mil A; Zabotti A; van der Heijde D; Smolen JS
Ann Rheum Dis; 2024 May; 83(6):706-719. PubMed ID: 38499325
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy.
Kim HA; Lee E; Park SY; Lee SS; Shin K
J Korean Med Sci; 2022 Aug; 37(33):e253. PubMed ID: 35996930
[TBL] [Abstract][Full Text] [Related]
19. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.
Yap KS; Ye JY; Li S; Gladman DD; Chandran V
Ann Rheum Dis; 2018 Nov; 77(11):1573-1577. PubMed ID: 30077991
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Inflammatory Versus Mechanical Back Pain in Individuals with Psoriatic Arthritis: A Review of the Literature.
Grinnell-Merrick LL; Lydon EJ; Mixon AM; Saalfeld W
Rheumatol Ther; 2020 Dec; 7(4):667-684. PubMed ID: 32935330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
